Product Information
MEXILETINE 200 MG CAPSULE is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.2627 per EA under NDC 31722003701. Its NADAC has been published 150 times since Oct 11, 2023.
FDA first approved this application on Nov 9, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722003701
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
MEXILETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216463FDA Approved
11/9/2022
TE Code
AB
On Market Since
11/9/2022
Pharmacological Classes
Price Statistics
The NADAC for MEXILETINE 200 MG CAPSULE has been published 150 times since Oct 11, 2023, and over the history we have for it it has declined 53.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2627 per EA |
|---|---|
| All-time high | $0.5663 (Oct 11, 2023) |
| All-time low | $0.2472 (May 21, 2025) |
| 52-week high | $0.3155 |
| 52-week low | $0.2570 |
| Median price | $0.2943 |
| Average price | $0.3238 |
| Largest weekly change | -32.6% (Nov 20, 2024) |
| Weeks tracked | 150 |
| Tracking since | Oct 11, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MEXILETINE 200 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MEXILETINE 200 MG CAPSULE, manufactured by Camber Pharmaceuticals Inc., is $0.2627 per EA (NDC 31722003701), effective Aug 19, 2026.
How has the price of MEXILETINE 200 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MEXILETINE 200 MG CAPSULE has declined 53.6%. It has been tracked across 150 weekly CMS publications since Oct 11, 2023.
What are the highest and lowest recorded NADAC prices for MEXILETINE 200 MG CAPSULE?
Since Oct 11, 2023, the NADAC for MEXILETINE 200 MG CAPSULE has ranged from a low of $0.2472 (May 21, 2025) to a high of $0.5663 (Oct 11, 2023), with a median of $0.2943 per EA.
Are there cheaper alternatives to MEXILETINE 200 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MEXILETINE 200 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures MEXILETINE 200 MG CAPSULE?
MEXILETINE 200 MG CAPSULE (NDC 31722003701) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.